Prilog u časopisu
Otvoreni pristup
The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes
Maack et al.1 described metabolic alterations and therapeutic interventions in patients with heart failure (HF) and diabetes. However, some mechanisms might have been overseen. Currently, only two antidiabetic agents (empagliflozin and liraglutide) c…